These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19827949)

  • 1. The use of second-generation antipsychotics and the changes in physical growth in children and adolescents with perinatally acquired HIV.
    Kapetanovic S; Aaron L; Montepiedra G; Sirois PA; Oleske JM; Malee K; Pearson DA; Nichols SL; Garvie PA; Farley J; Nozyce ML; Mintz M; Williams PL;
    AIDS Patient Care STDS; 2009 Nov; 23(11):939-47. PubMed ID: 19827949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between the use of second-generation antipsychotics and changes in total cholesterol levels in children and adolescents perinatally infected with HIV.
    Kapetanovic S; Aaron L; Williams PL; Farley J; Sirois PA; Garvie PA; Pearson DA; Oleske JM; Montepiedra G;
    Neurobehav HIV Med; 2010 Aug; 2010(2):39-48. PubMed ID: 20865061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of medications prescribed for treatment of attention-deficit hyperactivity disorder on physical growth in children and adolescents with HIV.
    Sirois PA; Montepiedra G; Kapetanovic S; Williams PL; Pearson DA; Malee K; Garvie PA; Kammerer BL; Nichols SL; Nozyce ML; Mintz M; Mitchell WG; Oleske JM;
    J Dev Behav Pediatr; 2009 Oct; 30(5):403-12. PubMed ID: 19827220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second-generation antipsychotics.
    de Hoogd S; Overbeek WA; Heerdink ER; Correll CU; de Graeff ER; Staal WG
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):166-73. PubMed ID: 22506734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study.
    Ilies D; Huet AS; Lacourse E; Roy G; Stip E; Amor LB
    Can J Psychiatry; 2017 Dec; 62(12):827-836. PubMed ID: 28673098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting.
    Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S
    J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weight Gain Effects of Second-Generation Antipsychotic Treatment in Autism Spectrum Disorder.
    Yoon Y; Wink LK; Pedapati EV; Horn PS; Erickson CA
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):822-827. PubMed ID: 27389348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era.
    Nachman SA; Chernoff M; Gona P; Van Dyke RB; Dankner WM; Seage GR; Oleske J; Williams PL;
    Arch Pediatr Adolesc Med; 2009 Feb; 163(2):164-71. PubMed ID: 19188649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children.
    Buchacz K; Cervia JS; Lindsey JC; Hughes MD; Seage GR; Dankner WM; Oleske JM; Moye J
    Pediatrics; 2001 Oct; 108(4):E72. PubMed ID: 11581480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth and the pubertal growth spurt in South African adolescents living with perinatally-acquired HIV infection.
    Mwambenu B; Ramoloko V; Laubscher R; Feucht U
    PLoS One; 2022; 17(1):e0262816. PubMed ID: 35077489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
    Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
    J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.
    Lipshultz SE; Williams PL; Wilkinson JD; Leister EC; Van Dyke RB; Shearer WT; Rich KC; Hazra R; Kaltman JR; Jacobson DL; Dooley LB; Scott GB; Rabideau N; Colan SD;
    JAMA Pediatr; 2013 Jun; 167(6):520-7. PubMed ID: 23608879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome.
    Degrauw RS; Li JZ; Gilbert DL
    Pediatr Neurol; 2009 Sep; 41(3):183-6. PubMed ID: 19664533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort Study.
    Ronsley R; Nguyen D; Davidson J; Panagiotopoulos C
    Can J Psychiatry; 2015 Oct; 60(10):441-50. PubMed ID: 26720191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.
    Ferrara M; Umlauf A; Sanders C; Meyer JM; Allen McCutchan J; Duarte N; Hampton Atkinson J; Grant I; Ellis RJ;
    Psychiatry Res; 2014 Aug; 218(1-2):201-8. PubMed ID: 24794030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.
    Correll CU; Penzner JB; Parikh UH; Mughal T; Javed T; Carbon M; Malhotra AK
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):177-206. PubMed ID: 16321730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.